Metoprololtartraat Cf

Metoprolol tartrate, the active ingredient in Metoprololtartraat Cf, is a beta blocker presented as an oral tablet for oral use. It is employed to manage hypertension, angina pectoris, chronic heart failure, post‑myocardial infarction care, and certain cardiac arrhythmias in adult patients. GNH USA supplies Metoprololtartraat Cf as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoprolol tartrate is a selective β1‑adrenergic antagonist used in several cardiovascular conditions. - Hypertension: lowers systemic blood pressure and reduces cardiovascular strain. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain. - Post‑myocardial infarction: improves survival by reducing cardiac workload. - Chronic heart failure: enhances ventricular function and reduces hospitalisation risk. - Cardiac arrhythmias: controls heart rate in atrial fibrillation and other rhythm disorders.

Metoprolol tartrate may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Fatigue or tiredness - Dizziness or light‑headedness - Cold extremities - Headache - Bradycardia (slow heart rate) - Gastrointestinal upset (nausea, abdominal discomfort)

Serious or Rare Side Effects: - Severe bradycardia or heart block - Marked hypotension - Bronchospasm, especially in patients with asthma - Allergic reactions (rash, angioedema) - Depression or mood changes - Worsening heart failure symptoms

Before initiating therapy, clinicians should consider several safety measures. - Monitor blood pressure: ensure values are within target range. - Assess heart rate: watch for excessive slowing. - Use caution in asthma or chronic obstructive pulmonary disease: β1‑selectivity may not fully protect airways. - Adjust dose in renal impairment: reduced clearance may increase exposure. - Avoid abrupt discontinuation: taper gradually to prevent rebound tachycardia or hypertension. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Metoprolol tartrate can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Verapamil or diltiazem: combined AV‑node blockade may cause severe bradycardia. - Clonidine withdrawal: abrupt cessation while on metoprolol can precipitate hypertension. - Insulin or oral hypoglycemics: β‑blockade may mask hypoglycaemia symptoms.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., quinidine, fluoxetine): may increase metoprolol plasma levels. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): can attenuate antihypertensive effect.